Inhibition of the progression of human and rat Wilms' tumor by Tiazofurin

Anticancer Research

Volumn 16, Issue 6 A, 1996, Pages 3333-3340

  Raso E ^a   Timar J ^a   Lapis, K ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Metastasis; Tiazofurin; Wilms tumor

Indexed keywords

TIAZOFURIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER RECURRENCE; CANCER SURGERY; CANCER TRANSPLANTATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; HUMAN; HUMAN TISSUE; KIDNEY CAPSULE; MALE; MOUSE; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR RECURRENCE;

ANIMALS; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; KIDNEY NEOPLASMS; MALE; MICE; MICE, SCID; ORGAN SIZE; RATS; RATS, INBRED F344; RIBAVIRIN; TRANSPLANTATION, HETEROLOGOUS; WILMS TUMOR;

EID: 0030513878     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Godzinski J, Moorman-Voestermans CG, Sawicz-Birkowska K, Tournade MF, Voute PA, de Kraker J, Weiricch A, Ludwig R, Gauthier F: Paediatric surgical oncology. 5. Nephroblastoma. International Society of Paediatric Oncology (SIOP) Nephroblastoma Trial and Study Committee. Eur J Surg Oncol 21(4): 414-418, 1995.
2. Coppes MJ: Wilms' tumor: to cure and understanding. Crit Rev Oncol Hematol 18(3): 179-196, 1995.
3. Ritchey ML, Pringle KCC, Breslow NE, Takashima J, Moksness J, Zuppan CW, Becckwith JB, Thomas PR, Kelalis PP: Management and outcome of inoperable Wilms tumor. A report of National Wilms Tumor Study-3 Ann Surg 220(5): 683-690, 1444.
4. Marina NM, Wiliams, JA, Meyer JA, Jones DP, Douglass EC, Pratt CB: Refining therapeutic strategies for patients with resistant Wilms tumor. Am JPediatr Hematol Oncol 16(4): 296-300, 1994.
5. Pritchard J, Imeson J, Barnes J, Cotterill S, Gough D, Marsden HB, Morris-Jones P, Pearson D: Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study. J Clin Oncol 13(1): 124-133, 1995.
6. Rásó E, Timár J, Paku S Lapis K: Metastasizing rat nephroblastoma A rodent Wilms' tumor model. Carcinogenesis 15(6): 1243-1249, 1994.
7. Lui MS, Faderan MA, Liepnieks JJ, Natsumeda Y, Olah E, Jayaram HN, Weber G: Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-β-D-ribofuranosylthiazole-4-carboxamide). J Biol Chem 259: 5078-5082, 1984.
8. Robins, RK, Srivastava RC, Narayanan VL: 2-β-D-ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases. J Med Chem 25: 107-108, 1982.
9. Dimery IW, Neidhart JA, McCarthy K, Krakoff IH, Hong WK: Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck. Cancer Treat Rep 71(4): 425-426, 1987.
10. Bogden AE, Von Hoff DD: Comparison of the human tumor cloning and subrenal capsule assay. Cancer Res 44: 1087-1090, 1984.
11. Weber G, Singhal RL, Prajda N, Yeh YA, Look KY, Sledge GW: Regulation of signal transduction. Adv Enzyme Regul 35: 1-21, 1995.
12. Olah E, Kote Z, Natsumeda Y, Yamaju Y, Jarai G, Lapis E, Financsek I, Weber G: Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells. Cancer Biochem Biophys 11(2): 107-117, 1990.
13. Cocco L, Marteli AM, Capitani S, Maraldi NM, Mazzotti G, Barnabei O, Gilmour RS, Manzoli FA: Nuclear inositol lipid cycle and differentiation Adv Enzyme Regul 35: 23-33, 1995.